Quarterly Call Option Transactions in Viking Therapeutics, Inc. (VKTX)
This table provides information about the institutional ownership of Viking Therapeutics, Inc. (VKTX) during . The information is specifically focused on institutions that hold call options of Viking Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2021 | 0 | 21,200 | 21,200 | 272,700 | 0 | 272,700 | -251,500 | |
| Q1 2022 | 32,000 | 0 | 32,000 | 70,500 | 0 | 70,500 | -38,500 | |
| Q2 2022 | 29,300 | 0 | 29,300 | 6,700 | 0 | 6,700 | 22,600 | |
| Q3 2022 | 13,900 | 0 | 13,900 | 2,100 | 0 | 2,100 | 11,800 | |
| Q4 2022 | 651,000 | 980,300 | 1,631,300 | 1,400 | 0 | 1,400 | 1,629,900 | |
| Q1 2023 | 647,100 | 909,142 | 1,556,242 | 157,800 | 0 | 157,800 | 1,398,442 | |
| Q2 2023 | 1,074,400 | 299,000 | 1,373,400 | 256,200 | 0 | 256,200 | 1,117,200 | |
| Q3 2023 | 11,000 | 1,426,300 | 1,437,300 | 1,456,600 | 0 | 1,456,600 | -19,300 | |
| Q4 2023 | 547,600 | 234,600 | 782,200 | 998,000 | 0 | 998,000 | -215,800 | |
| Q1 2024 | 3,548,000 | 1,842,775 | 5,390,775 | 79,100 | 0 | 79,100 | 5,311,675 | |
| Q2 2024 | 605,358 | 1,316,400 | 1,921,758 | 1,914,900 | 0 | 1,914,900 | 6,858 | |
| Q3 2024 | 573,800 | 550,300 | 1,124,100 | 452,700 | 0 | 452,700 | 671,400 | |
| Q4 2024 | 0 | 41,535 | 41,535 | — | 41,535 | |||